Autolus Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 53.6%.

Top 25 shareholders own 86.45% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.6%	Syncona Investment Management Limited	33,527,162	€130.5m	0%	40.27%
12.5%	BioNTech SE	33,333,333	€129.7m	0%	no data
8.93%	Blackstone Inc.	23,750,917	€92.4m	0%	0.36%
7.7%	Blackstone Life Sciences	20,485,611	€79.7m	0%	70.44%
6.03%	Paradigm Biocapital Advisors LP	16,028,002	€62.4m	27.1%	3.2%
5.87%	Deep Track Capital, LP	15,619,297	€60.8m	31.6%	2.11%
5.64%	Qatar Investment Authority	15,000,000	€58.4m	0%	0.21%
5.49%	Renata Kellnerova	14,612,275	€56.9m	0%	no data
3.03%	Wellington Management Group LLP	8,046,303	€31.3m	0%	0.01%
3.01%	Polygon Global Partners LLP	8,000,000	€31.1m	-33.3%	7.71%
3.01%	Tetragon Financial Management LP	8,000,000	€31.1m	-15.5%	99.88%
2.05%	Cormorant Asset Management, LP	5,450,000	€21.2m	1,290%	1.19%
1.45%	Armistice Capital LLC	3,850,000	€15.0m	-44.2%	0.4%
1.44%	Adage Capital Management, L.P.	3,825,532	€14.9m	0%	0.03%
1.41%	Frazier Life Sciences Management, LP	3,746,857	€14.6m	0%	0.65%
1.13%	T. Rowe Price Group, Inc.	3,001,208	€11.7m	0%	no data
0.7%	Lynx1 Capital Management LP	1,858,409	€7.2m	36.3%	1.59%
0.69%	Perceptive Advisors LLC	1,831,167	€7.1m	0%	0.17%
0.63%	Schroder Investment Management Limited	1,672,732	€6.5m	0%	no data
0.58%	Affinity Asset Advisors, LLC	1,550,408	€6.0m	-22.2%	1.47%
0.56%	J O Hambro Capital Management Limited	1,487,147	€5.8m	9.61%	0.04%
0.55%	BNY Mellon Asset Management	1,450,791	€5.6m	0%	no data
0.51%	BlackRock, Inc.	1,355,339	€5.3m	76.7%	no data
0.51%	Fred Alger Management, LLC	1,354,331	€5.3m	0%	0.03%
0.4%	Christian Itin	1,066,009	€4.1m	0%	no data